London’s Canary Wharf plans life sciences tower as finance retreats

London’s Canary Wharf plans life sciences tower as finance retreats By Reuters

Breaking News

‘;

Economy 1 hour ago (Dec 13, 2022 12:41)

LONDON (Reuters) – Canary Wharf Group is planning to build a 23-floor tower for the life sciences industry which it says will be Europe’s biggest such construction, as the London hub aims to diversify from a financial industry in retreat.

Canary Wharf Group (CWG) said on Tuesday the 823,000 square foot development will contain laboratories and workspaces, and is being built with Kadans Science Partner.

“We have been developing our vision for a world-class life sciences hub at Canary Wharf since 2019, and this is a significant milestone in our journey,” CWG Chief Executive Shobi Khan said.

The building comes as financial services companies looking to cut costs are reducing their presence in Canary Wharf, a regenerated district that was formerly London’s docklands area but now houses big banks such as Barclays (LON:BARC) and HSBC (LON:HSBA).

HSBC is reviewing whether to keep its global headquarters in the Wharf, Reuters reported in September, citing an internal memo.

Ratings agency Moody’s put CWG’s debt on review for a possible downgrade earlier this month, citing a possible 10-15% drop in office values over the next 18 months.

The coronavirus pandemic has conversely lifted interest in offices and laboratories dedicated to life sciences to a new level, Reuters reported in April last year.

Although less than 1% of European real estate investment is in life sciences, according to a recent report from the Urban Land Institute, strong government and venture capital investment in the sector is encouraging piggy-backing by real estate investors.

The Financial Times, which earlier reported the new life sciences tower, said the development could cost 500 million pounds ($615 million). CWG did not immediately respond to a request to confirm that figure.

($1 = 0.8135 pounds)

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.